铁剂

补充足够的铁剂是保证疗效的重要因素。

Enough chalybeate being supplemented is the important factor for ensuring the efficacy .

铁剂在治疗口腔白色念珠菌病中作用的研究

The study of chalybeate therapy in oral candidiasis albicans

结果各治疗组的疗效均有差异（P＜0.05），以血管内He&Ne激光、高压氧和铁剂的疗效为佳。

Results The differences of effective rate between different groups were significant ( P < 0 . 05 ) . The iron preparation , He - Ne laser and HBO had better effects .

钡剂和铁剂的信号随TE时间的延长而降低。

The signal of barium sulfate suspension and ferrous gluconate syrup were reduced with prolonging time of echo ( TE ) .

结论免疫口服液联合铁剂治疗IDA患儿免疫功能低下的疗效明显优于单纯使用铁剂治疗。

Conclusion Immunologic tonic combined with ferralium are better than ferralium only in treatment the children with IDA .

结论网织红细胞参数是评价IDA患者铁剂治疗反应敏感、可靠的早期指标。

Conclusion Reticulocyte indices are the sensitive and reliable early indicators to evaluate the effect of iron therapy in patients with IDA .

在补充铁剂前滴注小剂量抗坏血酸可以降低铁剂诱导的血清MDA峰值水平（P<0.001）；

Low dose intravenous infusion of ascorbic acid before infusion of iron dextrin could significantly decreased the peak level of plasma MDA induced by intravenous iron ( P < 0.001 ) .

结论在治疗HP阳性的慢性胃炎引起的IDA过程中，抗HP治疗能明显提高铁剂的治疗效果。

[ Conclusion ] It can increase the therapeutic effect of ferrous succinate when anti-HP was given in the IDA patients caused by chronic gastritis with HP positive .

目的：探讨小剂量铁剂治疗婴幼儿屏气发作（HBS）的疗效。

Objective : To discuses the effect of low dose iron therapy in infants with breath holding spell ( BHS ) .

结论乳酸亚铁片治疗IDA疗效好，胃肠不良反应轻，患者耐受性好，是治疗IDA安全、有效的口服铁剂。

CONCLUSION Ferrous Lactate tablet is a highly effective drug as Ferrous succinate tablets and with endurably mild side effects to patients with IDA .

此外并补充铁剂、叶酸、维生素B12、优质低蛋白饮食及其它对症及支持治疗。

In addition , supplementary iron , folic acid , vitamin B12 , high-quality low-protein diet , and other symptomatic and supportive care .

rHuEPO组及对照组75例均同时口服铁剂。

Meanwhile patients both in rHuEPO group and in control group ( 75 patients ) were taken oral iron supplement .

静脉铁剂治疗后Hb/Hct达标患者，EPO用量减少（与起始剂量相比，P<0.001）。

The dosage of EPO of those patients who receive IID and the value of Hb / Hct reach standard was significantly decreased ( P < 0.001 ) .

对于贫血严重的IDA患者，以及慢性胃肠道失血及慢性腹泻所致的IDA患者，更适于应用上述新型口服铁剂治疗。

These new type iron preparations were more effective for treatment of those IDA patients who had severe anaemia , sho were caused by chronic blood loss and chronic diarrhoea .

IDAI组给口服铁剂3w。

Patients in IDAI group were treated with oral iron for 3 weeks .

反流铁剂组免疫组织化学染色COX-2阳性率及阳性程度高于其他组（P<0.05），塞来昔布组与反流组比较差别无统计学意义（P>0.05）。

The levels of COX-2 expression in reflux adding iron group were significantly greater than other group and that was no differents between Celecoxib group and reflux adding iron group ( P > 0.05 ) .

结果提示轻度IDA对心肺功能和有氧能力的功能性损伤是存在的，但经过铁剂治疗这种功能性损伤是可以改善的。

This suggests , there were mild and functional impairment of heart and lungs as wellas aerobic power in children with mild IDA , which could be improved by iron treatment .

治疗成本包括铁剂、红细胞生成素（EPO）、化验检查和不良反应治疗等直接医疗成本，患者的交通、陪护和辅助营养保健品等直接非医疗成本以及患者劳动力损失的间接成本。

The treatment cost included the direct medical costs in iron product , EPO , medical examination and adverse events , and in direct medical costs in traffic , nursing , nutriment and the loss of labor .

每周补铁是铁剂补充的新的方式，已证实其在严格监控下，与每天补充60mg元素铁具有相同的改善贫血的效应，但在人群中实施的效果则由具体的社区条件所决定。

It was verified that weekly iron supplementation has the same efficacy with daily iron supplementation , while it 's effectiveness is determined by the local condition .

NH-F型除铁剂在镀镍溶液净化中的应用

The Application of NH-F Removing Iron Reagent in the Cleanness of Nickel Plating Solution

方法将50例IDA患儿随机分为2组，即铁剂治疗组（常规组）和免疫口服液联合铁剂治疗组（免疫口服液组），并选取条件相当的健康儿童20例作健康对照组。

Methods 50 children with IDA were randomly divided into two groups : the routine treatment group ( ferralium treatment ) and the group treated with immunologic tonic combined with ferralium , 20 healthy children as normal control group .

结果无反流组与无反流铁剂组未发生BE、异型增生和EA，反流铁剂组BE、异型增生及EA的发生率高于反流组与塞来昔布组（P<0.05）。

Results There are no BE , dysplasia and EA in former two groups . The incidence of BE , dysplasia and EA of reflux adding iron group were significantly higher than those of reflux group ( P < 0.05 ) and celecoxib group ( P < 0.05 ) .

背景血管紧张素转化酶抑制剂（ACEI）引起干咳的机制尚不完全清楚，有报道认为可能是由一氧化氮（NO）介导的，而补充铁剂能减少NO的生成并能降低NO相关的细胞损害。

Background The mechanism of angiotensin converting enzyme inhibitor ( ACEI ) induced cough has not been fully elucidated . One of possible mechanisms is ACEI increase nitric oxide ( NO ) generation , iron supplementation can inhibit this increase and NO related cell damage .

结论：rh-EPO能有效防治早产儿贫血，无明显副作用。目的评价重组人类促红细胞生成素（rhu-EPO）治疗极低出生体重早产儿贫血中补充铁剂的临床意义。

Conclusions : rh-EPO can prevent and cure the premature anemia effectively , and have no side-effect . Objective : To study the therapeutic effects of iron on anemia of prematurity in newborn infants .

两组同时补充铁剂和叶酸。

Folic acid and iron were used orally in both groups .

重组人促红细胞生成素和铁剂治疗慢性病贫血的临床研究

The clinical study of rhEPO and iron in treatment of ACD

铁剂诱发大鼠肝纤维化的组织学变化

Changes of hepatic fibrosis induced by iron overload in SD rats

学龄前儿童不同水平铁营养状况的铁剂试验治疗效果

A therapeutic trial of iron on preschool children with various iron status

病人口服双萘羟酸噻嘧啶及铁剂后痊愈。

The patients recovered after taking pyrantel pamoate and chalybeatus .

肾性贫血患者静脉铁剂使用中值得关注的问题

Concerns of intravenous iron therapy in patients with renal anemia